Literature DB >> 33130312

Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.

Chao Song1, Hanping Qi1, Yongsheng Liu1, Yunping Chen1, Pilong Shi1, Shu Zhang2, Jing Ren1, Lixin Wang1, Yonggang Cao1, Hongli Sun3.   

Abstract

Emerging evidence reveals that autophagy plays crucial roles in cardiac hypertrophy. Long noncoding RNAs (lncRNAs) are novel transcripts that function as gene regulators. However, it is unclear whether lncRNAs regulate autophagy in cardiac hypertrophy. Here, we identified a novel transcript named lncRNA Gm15834, which was upregulated in the transverse aortic constriction (TAC) model in vivo and the angiotensin-II (Ang-II)-induced cardiac hypertrophy model in vitro and was regulated by nuclear factor kappa B (NF-κB). Importantly, forced expression of lncRNA Gm15834 enhanced autophagic activity of cardiomyocytes and promoted myocardial hypertrophy, whereas silencing of lncRNA Gm15834 attenuated autophagy-induced myocardial hypertrophy. Mechanistically, we found that lncRNA Gm15834 could function as an endogenous sponge RNA of microRNA (miR)-30b-3p, which was downregulated in cardiac hypertrophy. Inhibition of miR-30b-3p enhanced cardiomyocyte autophagic activity and aggravated myocardial hypertrophy, whereas overexpression of miR-30b-3p suppressed autophagy-induced myocardial hypertrophy by targeting the downstream autophagy factor of unc-51-like kinase 1 (ULK1). Moreover, inhibition of lncRNA Gm15834 by adeno-associated virus carrying short hairpin RNA (shRNA) suppressed cardiomyocyte autophagic activity, improved cardiac function, and mitigated cardiac hypertrophy. Taken together, our study identified a novel regulatory axis encompassing lncRNA Gm15834/miR-30b-3p/ULK1/autophagy in cardiac hypertrophy, which may provide a potential therapy target for cardiac hypertrophy.
Copyright © 2020 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NF-κB; ULK1; autophagy; cardiac hypertrophy; lncRNA Gm15834; miR-30b-3p

Mesh:

Substances:

Year:  2020        PMID: 33130312      PMCID: PMC7934579          DOI: 10.1016/j.ymthe.2020.10.024

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  44 in total

Review 1.  Autophagy in health and disease: a double-edged sword.

Authors:  Takahiro Shintani; Daniel J Klionsky
Journal:  Science       Date:  2004-11-05       Impact factor: 47.728

Review 2.  Long non-coding RNAs: insights into functions.

Authors:  Tim R Mercer; Marcel E Dinger; John S Mattick
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

Review 3.  Regulation of cardiac hypertrophy by intracellular signalling pathways.

Authors:  Joerg Heineke; Jeffery D Molkentin
Journal:  Nat Rev Mol Cell Biol       Date:  2006-08       Impact factor: 94.444

4.  Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis.

Authors:  R Zeller; K D Bloch; B S Williams; R J Arceci; C E Seidman
Journal:  Genes Dev       Date:  1987-09       Impact factor: 11.361

5.  Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy.

Authors:  Dian J Cao; Zhao V Wang; Pavan K Battiprolu; Nan Jiang; Cyndi R Morales; Yongli Kong; Beverly A Rothermel; Thomas G Gillette; Joseph A Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-18       Impact factor: 11.205

6.  The association of AMPK with ULK1 regulates autophagy.

Authors:  Jong Woo Lee; Sungman Park; Yoshinori Takahashi; Hong-Gang Wang
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

Review 7.  Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.

Authors:  Christopher G Proud
Journal:  Cardiovasc Res       Date:  2004-08-15       Impact factor: 10.787

8.  The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress.

Authors:  Atsuko Nakai; Osamu Yamaguchi; Toshihiro Takeda; Yoshiharu Higuchi; Shungo Hikoso; Masayuki Taniike; Shigemiki Omiya; Isamu Mizote; Yasushi Matsumura; Michio Asahi; Kazuhiko Nishida; Masatsugu Hori; Noboru Mizushima; Kinya Otsu
Journal:  Nat Med       Date:  2007-04-22       Impact factor: 53.440

9.  Blockade of NF-kappaB using IkappaB alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice.

Authors:  David Young; Zoran B Popovic; W Keith Jones; Sudhiranjan Gupta
Journal:  J Mol Biol       Date:  2008-06-05       Impact factor: 5.469

Review 10.  Autophagy: a target for therapeutic interventions in myocardial pathophysiology.

Authors:  Antonis Halapas; Athanasios Armakolas; Michael Koutsilieris
Journal:  Expert Opin Ther Targets       Date:  2008-12       Impact factor: 6.902

View more
  8 in total

1.  Long chain noncoding RNA-ROR promotes hypoxic injury of cardiomyocytes by targeting the miR-145/HAX-1 axis.

Authors:  Ya Yang; Qianmei Tang; Yu Li; Lianjing Dai; Minfeng Li; Yongxin Fu
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

Review 2.  Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy.

Authors:  Joana Silva; Paula A da Costa Martins
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

3.  Suppression of lncRNA Gm47283 attenuates myocardial infarction via miR-706/ Ptgs2/ferroptosis axis.

Authors:  Feng Gao; Yongcheng Zhao; Bin Zhang; Chunwei Xiao; Zhanfa Sun; Yuan Gao; Xueyong Dou
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  Neutrophil-like cell membrane-coated siRNA of lncRNA AABR07017145.1 therapy for cardiac hypertrophy via inhibiting ferroptosis of CMECs.

Authors:  Pilong Shi; Minghui Li; Chao Song; Hanping Qi; Lina Ba; Yonggang Cao; Meitian Zhang; Yawen Xie; Jing Ren; Jiabi Wu; Ping Ren; Hongli Sun
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-03       Impact factor: 8.886

5.  Characterization and Validation of ceRNA-Mediated Pathway-Pathway Crosstalk Networks Across Eight Major Cardiovascular Diseases.

Authors:  Chao Song; Jian Zhang; Yongsheng Liu; Yinling Hu; Chenchen Feng; Pilong Shi; Yuexin Zhang; Lixin Wang; Yawen Xie; Meitian Zhang; Xilong Zhao; Yonggang Cao; Chunquan Li; Hongli Sun
Journal:  Front Cell Dev Biol       Date:  2022-04-01

Review 6.  Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications.

Authors:  Ling Zou; Minru Liao; Yongqi Zhen; Shiou Zhu; Xiya Chen; Jin Zhang; Yue Hao; Bo Liu
Journal:  Acta Pharm Sin B       Date:  2022-06-11       Impact factor: 14.903

7.  LncRNA Gm43843 Promotes Cardiac Hypertrophy via miR-153-3p/Cacna1c Axis.

Authors:  Yuhua Cai; Yunpeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-10       Impact factor: 2.650

8.  LncRNA4930473A02Rik promotes cardiac hypertrophy by regulating TCF7 via sponging miR-135a in mice.

Authors:  Jing Ren; Hanping Qi; Chao Song; Lina Ba; Renling Liu; Xiang Feng; Lixin Wang; Meitian Zhang; Yawen Xie; Hongli Sun
Journal:  Cell Death Discov       Date:  2021-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.